文献速递复苏、休克与脓毒症呼吸衰竭与机械通气

自动机械胸外按压装置CPR中容量控制、压力控制与胸外按压诱导通气的比较:一项随机临床预试验

Comparison of volume-controlled, pressure-controlled, and chest compression-induced ventilation during cardiopulmonary resuscitation with an automated mechanical chest compression device: A randomized clinical pilot study.
PubMed 文献 · Resuscitation · 2021-07-22
一句话结论使用自动机械胸外按压装置行CPR时,BIPAP、CPAP与VCV均能达到足够分钟通气量,但BIPAP潮气量更高,推荐优先选择BIPAP以降低死腔通气风险。

该随机对照预试验纳入30例院外心脏骤停到达复苏室并接受自动机械胸外按压装置(AMCCD)胸外按压、预期继续按压至少15分钟的患者,随机分为BIPAP辅助自主呼吸、CPAP和容量控制通气(VCV)三组,比较研究期间的潮气量、分钟通气量和呼气末CO2。结果显示CPAP组潮气量(68 [64-83] ml)显著低于BIPAP组(349 [137-500] ml)(p<0.05);CPAP组分钟通气量(6.2 [5.3-8.1] l/min)与BIPAP组(7.1 [6.7-10.2] l/min)及VCV组(7.2 [3.7-8.4] l/min)存在差异。所有通气模式均达到足够的分钟通气量,但BIPAP因潮气量更高可能更优,作者推荐使用AMCCD时以BIPAP模式启动机械通气以避免死腔通气相关风险。

要点

  • 在AMCCD胸外按压的院外心脏骤停患者中,CPAP组潮气量(68 [64-83] ml)显著低于BIPAP组(349 [137-500] ml)(p<0.05)。
  • CPAP组分钟通气量(6.2 [5.3-8.1] l/min)与BIPAP组(7.1 [6.7-10.2] l/min)和VCV组(7.2 [3.7-8.4] l/min)存在差异。
  • 所有三种通气模式(BIPAP、CPAP、VCV)在AMCCD CPR期间均达到足够的分钟通气量。
  • 作者推荐使用AMCCD时以BIPAP模式启动机械通气,以避免死腔通气相关风险。
  • 该研究为预试验,样本量小(30例随机),结论需进一步验证。

适用人群与场景

  • 纳入院外心脏骤停到达复苏室、接受自动机械胸外按压装置(AMCCD)胸外按压且预期继续按压至少15分钟的患者。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 使用AMCCD行CPR时,作者推荐以BIPAP模式启动机械通气,以避免死腔通气相关风险。
  • 原文未提及具体药物剂量、给药途径、频次或目标值。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 研究类型:随机对照预试验;样本量:筛查53例,随机30例;单中心(原文未明确说明中心数,但为复苏室单场景研究)。
  • 人群:院外心脏骤停到达复苏室、接受AMCCD胸外按压且预期继续至少15分钟的患者。
  • 干预与对照:随机分为BIPAP辅助自主呼吸组、CPAP组和VCV组。
  • 主要终点结果:CPAP组潮气量(68 [64-83] ml)显著低于BIPAP组(349 [137-500] ml)(p<0.05);CPAP组分钟通气量(6.2 [5.3-8.1] l/min)与BIPAP组(7.1 [6.7-10.2] l/min)和VCV组(7.2 [3.7-8.4] l/min)存在差异。
  • 关键次要终点及不良事件:原文未提及。

证据类型、等级与局限

  • 证据类型:随机对照预试验(RCT pilot)。
  • 证据等级或推荐强度:原文未提及。
  • 局限:样本量小(30例随机),为预试验,原文未提及盲法、单中心或多中心信息。

对床旁实践的改变

  • 使用AMCCD行CPR时,可优先选择BIPAP模式启动机械通气,以提供更高的潮气量并避免死腔通气风险。
  • CPAP模式在AMCCD CPR中潮气量显著较低,需注意死腔通气风险。
  • 该结论来自小样本预试验,需在更大规模研究中验证,不适用于未使用AMCCD的CPR场景。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

AIM OF THE STUDY: Automated mechanical chest compression devices (AMCCDs) can help performing high-quality cardiopulmonary resuscitation (CPR). Guidelines for CPR are lacking information about the optimal ventilation mode during CPR using AMCCDs. Aim of this pilot study was to compare three common ventilation modes during CPR using AMCCD.

METHODS: In this randomized controlled trial, we included patients with an out-of-hospital cardiac arrest arriving at the resuscitation room receiving chest compressions via AMCCD with an expected continuation of at least 15 min. Patients were randomly assigned to three groups: biphasic positive airway pressure with assisted spontaneous ventilation (BIPAP) with assisted spontaneous breathing, continuous positive airway pressure (CPAP) and volume-controlled ventilation (VCV). Outcomes were tidal volume, respiratory minute volume, and end-tidal CO2 during the study period. Groups were compared using generalized linear models. Data is given as median and interquartile ranges.

RESULTS: Of 53 screened patients, 30 were randomized. The tidal volume was significantly (p < 0.05) lower in patients of the CPAP group (68 [64-83] ml) compared with those of the BIPAP (349 [137-500] ml), while the respiratory minute volume differed between the CPAP group (6.2 [5.3-8.1] l/min) and both the BIPAP (7.1 [6.7-10.2] l/min) and VCV group (7.2 [3.7-8.4] l/min).

CONCLUSIONS: All ventilation modes achieved an adequate respiratory minute volume during CPR with an AMCCD. However, BIPAP seems to be superior due to the higher tidal volume. Therefore, we recommend starting mechanical ventilation when using AMCCD with BIPAP ventilation to avoid risks related to dead space ventilation.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Fuest K, Dorfhuber F, Lorenz M, et al. Comparison of volume-controlled, pressure-controlled, and chest compression-induced ventilation during cardiopulmonary resuscitation with an automated mechanical chest compression device: A randomized clinical pilot study. Resuscitation. 2021. PMID: 34302927. doi:10.1016/j.resuscitation.2021.07.010

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。